Efficacy markers in depression
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Current antidepressant agents are similar in efficacy to the original drugs discovered in the 1950s. The development of new treatments for depression is, however, limited by the absence of validated human biomarker models to predict efficacy, clinical profile and dosing. Such models need to meet key criteria for biomarkers including sensitivity, specificity and relevance to depression. Here we review studies exploring whether early changes in emotional processing with antidepressant drug administration meet these criteria. A large body of evidence suggests that changes in emotional memory are particularly relevant to depression and to antidepressant drug action whereas changes in attentional processing are sensitive to anxiolytic drugs. These tasks are not consistently affected by agents which have failed in clinical trials in depression, but do show changes in the predicted direction with agents associated either with amelioration or induction of symptoms. Hence, early assessment of novel drugs on emotional processing may predict likely clinical effects and dosing prior to randomized controlled trials. Greater validation is required to assess whether these effects are an obligatory component of effective treatment of depression and whether use of these models can improve the accuracy of go/no-go decisions in drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At the functional level, depression is conceived of as a network level disorder, meaning that multiple brain regions including frontal, striatal, and limbic areas in interaction account for the symptoms of the disorder.11,12,39-41”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [40]
In the citing paper
“In anxiety and depression, modulating stress and emotional responsiveness is an important target for treatment and is associated with clinical improvement (Harmer et al., 2011).”
From Approaching the biology of human parental attachment: Brain imaging, oxytocin and coordinated assessments of mothers and fathers (2014) · cites this paper as Harmer et al., 2011
In the citing paper
“However we have reason to be cautiously optimistic given recent possible brain imaging studies where biomarkers for depression and its treatment are becoming established (Harmer et al., 2011).”
From Approaching the biology of human parental attachment: Brain imaging, oxytocin and coordinated assessments of mothers and fathers (2014) · cites this paper as Harmer et al., 2011
Citations
Cites
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Cognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · cited 1×
“The World Health Organization has therefore identified depression as an urgent health priority with the pressing need for more effective treatment options (Moussavi et al., 2007).”
BackgroundNeurobiology of emotion perception I: the neural basis of normal emotion perception
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00168-9 · Cited by 2,173 · cited 2×
“…may be able to get closer to the cognitive and psychological processes seen in depression and utilize our growing understanding of normal and abnormal emotional processes which have been investigated using a wide variety of techniques in humans (Clark et al., 2009; Phillips et al., 2003a, 2003b).”
BackgroundThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009 · cited 1×
“…interest in effects of antidepressants on hypothalamic–pituitary–adrenal (HPA) function, immune responsively, cellular plasticity, and neurogenesis (for example see Pariante and Lightman, 2008; Pittenger and Duman, 2008), all or any of which may contribute significantly to therapeutic actions.”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 1×
“…interest in effects of antidepressants on hypothalamic–pituitary–adrenal (HPA) function, immune responsively, cellular plasticity, and neurogenesis (for example see Pariante and Lightman, 2008; Pittenger and Duman, 2008), all or any of which may contribute significantly to therapeutic actions.”
BackgroundNeurobiology of emotion perception II: implications for major psychiatric disorders
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00171-9 · Cited by 1,736 · cited 2×
“…may be able to get closer to the cognitive and psychological processes seen in depression and utilize our growing understanding of normal and abnormal emotional processes which have been investigated using a wide variety of techniques in humans (Clark et al., 2009; Phillips et al., 2003a, 2003b).”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · cited 1×
“Hence, it is interesting that while reboxetine increases responses to reward more effectively than citalopram in the chocolate fMRI model, meta-analyses suggest that this drug may be less effective (Cipriani et al., 2009) in the overall clinical treatment of depression.”
BackgroundA cognitive-motivational analysis of anxiety.
Mogg, K., & Bradley, B. P. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(98)00063-1 · Cited by 1,642 · cited 2×
“The dot-probe measure is believed to have advantages over other measures of emotional attention such as the emotional Stroop task since it allows assessment of the timing of effects on attentional processing by presenting stimuli and probes at different durations (Mogg and Bradley, 1998).”
BackgroundMethodMacLeod, C., Rutherford, E., Campbell, L., Ebsworthy, G., & Holker, L. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.1.107 · Cited by 1,334
Research works printed but not linked: 1
- Chan SW, 2007, Psychol Med, 1
Cited by
How do antidepressants work? New perspectives for refining future treatment approaches
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30015-9 · Cited by 616
Self-citationThe impact of anxiety upon cognition: perspectives from human threat of shock studies
Robinson, O. J., Vytal, K., Cornwell, B. R., & Grillon, C. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00203 · Cited by 613
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
“, 2009, Chamberlain and Sahakian 2006) and may represent an important target for treatment (Clark et al., 2009; Harmer et al., 2010).”
BackgroundInfluentialSwain, J. E., Kim, P., Spicer, J., Ho, S. S., Dayton, C. J., Elmadih, A., & Abel, K. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.007 · Cited by 290
“More depressive symptoms were also associated with less activity in response to own vs. other baby cry in the OFC, dorsal ACC, and superior frontal gyrus - regions important for emotion information processing and regulation, including valence and salience.”
Influential
Metadata
- Authors
- Harmer, C. J., Cowen, P. J., & Goodwin, G. M.
- Affiliations
- Warneford Hospital (GB)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-06-08
- Volume
- 25
- Issue
- 9
- Pages
- 1148-1158
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2041484073
- Cited by
- 122
- References
- 76
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 5 · 2017: 4 · 2016: 10 · 2015: 17 · 2014: 8 · 2013: 13 · 2012: 11
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- depression, antidepressants, biomarkers, drug efficacy prediction, emotional memory, attentional processes, anxiolytics, antidepressant drug development
- MeSH terms
- Animals, Antidepressive Agents, Clinical Trials as Topic, Decision Making, Depressive Disorder, Major, Major Depressive Disorder, Emotions, Humans, Sensitivity and Specificity, Drug Design, Biomarkers, Pharmacological, Validation Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy markers in depression. https://app.cochat.ai/papers/10.1177/0269881110367722
- The paper
- Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011). Efficacy markers in depression. Journal of Psychopharmacology. https://doi.org/10.1177/0269881110367722
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.